MAL2 and renal carcinoma: Metastasis‐associated lung adenocarcinoma transcript 1 (MALAT1), for instance, is linked with a limited prognosis of bladder cancer, facilitating the clinical metastasis and progression of the cancer8; miR‐384 is a potential therapeutic target for renal carcinoma due to its function of suppressing cell growth and transformation9; mal T cell differentiation protein 2 (MAL2) is recognized as a tumor progression factor in multiple types of human cancers.10